PRIMARY SDM
Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse
AI Description
This is a qualitative and quantitative study that seeks to obtain information from patients with degenerative mitral valve prolapse and providers regarding factors important in deciding between surgical mitral valve repair (MVR) and transcatheter edge-to-edge repair (TEER). Findings from this study will provide data that can be used to develop decision aids that can assist patients in decision making between these two therapies and assist providers in integrating shared decision making the within the multidisciplinary heart valve team.
- Who can join
- adult, older adult
- Participants
- 150
- Expected completion
- 2025-02-28
- Funded by
- other
Conditions studied
Mitral Valve Prolapse
What is being tested
- OTHER: Focus Group/Quantitative Survey for HCPs
- OTHER: Focus Groups/Quantitative Survey for Patients
- OTHER: Qualitative Focus Group
What it measures
- Identify barriers and facilitators to implementing shared decision making (SDM) in multidisciplinary mitral valve Heart Teams, To support the future implementation of SDM, the investigators will evaluate the process of introducing SDM into local Heart Teams by conducting qualitative interviews across HCP stakeholders. Key stakeholders will include multidisciplinary groups of HCPs, ancillary staff, and administrators. These data will be used to map workflows and identify the optimal timing and process of integrating SDM in clinical care. In addition to generating process maps, an understanding of the implementation barriers and facilitators will aid in developing an approach to create and test an implementation strategy for SDM in severe degenerative MR., 1 year
- Identify outcomes most important to healthcare providers (HCPs) in recommendingTEER or MVR, The investigators will conduct qualitative focus groups among cardiac surgeons, referring cardiologists, interventional cardiologists who perform TEER, and nurses involved in the care of patients with degenerative MR to characterize outcomes important to HCPs when evaluating MVR versus TEER. Using similar methods as above, the investigators will then use these data to create and administer a quantitative point allocation survey to characterize how HCPs prioritize outcomes when evaluating treatment options for severe degenerative MR patients., 1 year
- Identify outcomes most important to patients with severe degenerative MR considering TEER or MVR, The investigators will conduct qualitative focus groups among patients with severe degenerative MR to elicit the range of outcomes patients consider important when selecting treatment options. These data will be analyzed to develop a consolidated framework of outcomes patients value. Using these data, the investigators will then create and administer a quantitative survey to characterize how patients with severe MR prioritize outcomes when making treatment decisions., 1 year
Working with
Cedars-Sinai Medical Center, Saint Luke's Mid America Heart Institute, The Cleveland Clinic, University of Kansas Medical Center, West Virginia University
Centers Participating
These centers are participating in this study. Reach out to them directly to learn more.
Registry entry updated 2024-12-17
Deciding whether to join a study is your choice, and you can ask a study team questions before you decide anything.
If you would rather we did it with you, call us on (656) 206-4686.